Semaglutide
US$ 27.17
obesity drug news today october 2025 glp-1 Exploring the Side Effects of GLP -1 Receptor WHO Decision Recognizing Obesity as
Description
Patients with statin intolerance should first consider evidence-based alternatives like ezetimibe, bempedoic acid, PCSK9 inhibitors, or inclisiran before considering GLP-1 therapy primarily for lipid management
Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department
Most studies have shown that many people who stop using the GLP-1 drugs regain weight they lost while taking them
Whats your view on balancing GLP-1 market momentum with safety in India
[RxSS data
